Not FDA approved and sold as a research chemical. This page is educational information only. It is not medical advice and not a recommendation to use anything.

IndexedBuilt automatically from public databases on 2026-09-30. Not yet hand-reviewed by PLOBT.How this works →

Alexamorelin

Not FDA approved

Growth hormone secretagogue peptide

Also known as: DA-70688

Evidence score

34/ 100

Emerging evidence

Early evidence, mostly unproven in humans

Regulatory standing. Sold as a research chemical, not approved
Limited human data. Some human data exists, not conclusive
No registered human trials. Nothing registered on ClinicalTrials.gov
1 cited source. Includes primary / regulatory sources

Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.

What it is

Alexamorelin is a synthetic peptide in the growth hormone releasing peptide family, related to compounds like hexarelin and GHRP-6. It is thought to act on the ghrelin receptor (growth hormone secretagogue receptor) to stimulate growth hormone release from the pituitary, and early studies suggested it may also raise ACTH, cortisol, and prolactin.

What the evidence shows

Automatic summaryLimited human data

A small number of older, short-term human studies measured hormone responses after administration, but there are no registered clinical trials and no evidence of long-term benefit or safety. It is not FDA-approved for any use, and the overall literature is thin, with about 8 published papers.

Key facts

Molecular formula

C50H63N13O7

Molecular weight

958.1 g/mol

Registered human trials

Live from ClinicalTrials.gov, refreshed daily.

0registered studies

Nonemost advanced phase

0completed (sample)

0recruiting (sample)

Published literature

Live from Europe PMC. This is how much has been published, not how much is proven in humans.

8papers referencing Alexamorelin

Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.

Anal Bioanal Chem2011

Metabolism of growth hormone releasing peptides.

Anal Chem2012

Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.

J Chromatogr A2012

Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

J Sep Sci2016

Sources

Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.